Please join us to celebrate this year’s finalists of the Activator 2025 at our Innovation Showcase on May 14. Six startup teams will showcase their technology to a panel of VCs and industry experts and compete for exciting awards. This event is a fantastic opportunity to meet a host of biotech entrepreneurs, pharma executives and venture capitalists. This is your chance to connect with like-minded individuals across institutions, discover cutting-edge ideas, and support the local startup community.
AGENDA
- Pre-Event Registration: 4:30-5:00 pm
- Opening Remarks: 5:10 pm
- Pitch Showcase: 5:15-6:00 pm
- Keynote Speaker & Closing Remarks: 6:00-6:30 pm
- Reception: 6:30-7:00 pm
We are thrilled to welcome Dr. Geoffrey Lynn as this year’s Keynote Speaker. A visionary biotech entrepreneur, Geoffrey co-founded and led Avidea Technologies, Inc. from its launch at Johns Hopkins FastForward in 2017 to its successful acquisition by Vaccitech, Plc in 2021—now known as Barinthus Biotherapeutics (NASDAQ: BRNS). As a former NIH-Oxford Scholar, he brings a unique perspective that bridges the worlds of Johns Hopkins and the NIH, embodying the spirit of scientific innovation and translational impact.
Nucleate is a non-profit with programming to support the commercialization of projects by academic trainees in the Baltimore and DC area. In our chapter’s history, we have worked with founders such as Taylor Cottle at Aptabridge, Alexander Trick at Prompt Diagnostics, and Mitchell Turley at Somnair, as well as sponsors including Blackbird Labs. Nucleate has served over 250 life sciences ventures that have raised over $320 million in venture funding across projects born out of more than 120 academic institutions.